from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2464c/-

LFCtreatmentdescriptionclass of inhibitor

0.759

Amikacinug/mL Amikacintranslation

1.226

Cap5-10ug/mL Capreomycintranslation

1.487

Rox10-50 ug/mL Roxithromycintranslation

0.788

SM2-5 ug/mL Streptomycintranslation

2.340

Tet5-10 ug/mL Tetracyclinetranslation

0.367

Rif0.2-5ug/mL Rifampicintranscription

0.134

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.773

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.461

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.579

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.939

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.541

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.326

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.452

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.946

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.411

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.817

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.032

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.120

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.201

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.020

KCN5-20 ug/mL Potassium cyaniderespiration

0.925

NaN30.2-2 mM Sodium aziderespiration

0.431

Nigericin50 uM Nigericinrespiration

-0.573

TRC10-150 ug/mL Triclosanrespiration

-2.233

TRZ10-25 ug/mL Thioridazinerespiration

1.223

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.004

menadione6-10 ug/mL Menadionerespiration

-0.180

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.256

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.673

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.413

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.190

NRP_1Non-replicating persistence stage 1dosRassociated

-0.400

Amp0.2mg/mL AmpicillincellWall

-0.334

Cephalexin20-100 ug/mL CephalexincellWall

-0.111

Cerulenin0.32-5 ug/mL CerulenincellWall

0.142

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.062

EMB10-20 ug/mL EthambutolcellWall

0.154

Eta12-40 ug/mL EthionamidecellWall

-0.063

INH0.2-0.4 ug/mL IsoniazidcellWall

0.070

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.550

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.070

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.515

BZA0.12 mg/mL BenzamidearomaticAmides

0.095

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.077

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.158

H2O24 mM hydrogen peroxideDNAdamaging

-0.024

Levo10 ug/mL LevofloxacinDNAdamaging

0.011

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.625

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.386

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.397

UVUV-irradiationDNAdamaging

2.116

ARP41-4 ug/mL Antitubercular compound ARP4?

0.038

Antimycin12.5-50 ug/mL Antimycin A?

0.132

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.368

PA_110-50 ug/mL Antitubercular compound PA-1?

0.103

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.011

PA8240.2-2 ug/mL PA-824?

-0.585

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.432

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.186

Verapamil50 uM Verapamil?

0.105

mercaptoethanol2 mM 2-Mercaptoethanol?

0.508

methoxatin10-20 ug/mL Methoxatin?